Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Aggiornamento

Anafilassi: miti, fatti e controversie

Anaphylaxis: myths, facts and controversies - a practical guide

Giuseppe Vieni1, Maria Rita Genovese2, Loretta Biserna1, Giulia Graziani1, Irene Berti2, Federico Marchetti1

1UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
2Clinica Pediatrica, IRCCS Materno-Infantile “Burlo Garofolo”, Trieste

Marzo 2019 - pagg. 154 -160

Abstract
Anaphylaxis is a condition that produces great anxiety throughout the scientific community and that often causes a significant impairment of the quality of life of patients and their families. The present article critically reports all the (false) myths and controversies on anaphylaxis on the basis of scientific evidences and clinical practice in real life. In particular, it shows that anaphylaxis is not lethal and indeed in the majority of cases it is a self-limiting condition. It may manifest without cutaneous and mucosal symptoms (10- 20% of cases) or with a late onset of such symptoms. It is not always possible to identify a trigger factor nonetheless the diagnosis cannot be excluded in front of a compatible clinical picture. Adrenaline, the pivotal therapy for anaphylaxis, is not dangerous if correctly administered. Antihistamine and cortisone do not cure anaphylaxis and must not delay administration of adrenaline. Moreover, anaphylaxis is unpredictable and there are not absolute predictive factors. Many factors may lead to more severe reactions, however none of them is predictive of death risk. There are not absolute criteria for the prescription of self-injecting adrenaline, therefore it must be assessed case by case (considering patients and their families). Anyhow, the sole prescription of adrenaline is not life- saving. In general, anaphylaxis is not a contraindication for vaccinations and in particular the one for egg allergy is not a contraindication for MMR and flu vaccines.
Contenuto riservato

Per leggere l'articolo completo è necessario effettuare il login.

Non sei ancora registrato? Registrati

Bibliografia
di riferimento • Anagnostou K, Turner PJ. Myths, facts and controversies in the diagnosis and management of anaphylaxis. Arch Dis Child 2019;104(1):83-90. • Dubois AEJ, Turner PJ, Hourihane J, et al. How does dose impact on the severity of food-induced allergic reactions, and can this improve risk assessment for allergenic foods? Report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop. Allergy 2018;73(7):1383-92. • Kennedy J, Stallings A, Platts-Mills T, et al. Galactose-alpha-1,3-galactose and delayed anaphylaxis, angioedema, and urticarial in children. Pediatrics 2013;131(5):e1545-52. • Lenchner KI, Ditto AM. Idiopathic anaphylaxis. Allergy Asthma Proc 2004;25(4 Suppl 1):S54-6. • Muraro A, Roberts G, Worm M, et al.; EAACI Food Allergy and Anaphylaxis Guidelines Group. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014;69(8):1026-45. • Muraro A, Roberts G, Clark A, et al.; EAACI Task Force on Anaphylaxis in Children. The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology. Allergy 2007;62(8):857-71. • Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease / Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117(2):391-7. • Simons FE, Ardusso LR, Bilò MB, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014;7(1):9. • Simons FE, Ardusso LR, Bilò MB, et al.; World Allergy Organization. World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2011;4(2):13-37. • Turner PJ, Baumert JL, Beyer K, et al. Can we identify patients at risk of life-threatening allergic reactions to food? Allergy 2016;71 (9):1241-55. • Umasunthar T, Leonardi-Bee J, Hodes M, et al. Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy 2013;43 (12):1333-41. • Yee CSK, El Khoury K, Albuhairi S, et al. Acquired cold-induced urticaria in pediatric patients: a 22-year experience in a tertiary care Center (1996-2017). J Allergy Clin Immunol Pract 2019;7(3):1024-31.

Corrispondenza: giuseppe.vieni@auslromagna.it